COVID-19相关白质脑病的长期神经影像随访
本文报告两例COVID-19相关白质脑病患者的长期神经影像随访,展示脑MRI在评估重症COVID-19患者神经症状、诊断潜在神经损伤及预测恢复中的价值。白质脑病可能导致慢性神经表现并预示神经恢复不良,随访影像出现白质软化可能提示不可逆白质损伤,与更严重的慢性缺陷相关。
要点
- 脑MRI可用于重症COVID-19患者神经症状的评估与预后判断
- 白质脑病可能预示神经恢复不良及慢性神经表现
- 随访出现白质软化提示不可逆白质损伤
核心结论
- COVID-19相关白质脑病可导致慢性神经表现并可能预示神经恢复不良。
- 随访神经影像出现白质软化可能是不可逆白质损伤的指标,与更严重的慢性缺陷相关。
研究设计与样本
- 本文为两例COVID-19相关白质脑病患者的长期神经影像随访报告。
关键影像表现/征象
- 随访神经影像显示白质软化,提示不可逆白质损伤。
临床应用与阅片要点
- 对重症COVID-19伴神经症状患者,脑MRI可用于诊断潜在神经损伤并预测恢复。
- 随访影像出现白质软化时,应提示临床可能为不可逆白质损伤及更严重的慢性缺陷。
局限性
- 仅两例病例报告,结论的普遍性有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
More than a year after the start of the COVID-19 pandemic, long-term neurological manifestations of COVID-19 are increasingly being reported. The long-term sequelae of COVID-19-related leukoencephalopathy, however, remain unclear. Here, we present long-term neuroimaging follow-up in two cases of COVID-19-related leukoencephalopathy. The two cases demonstrate the utility of brain MRI for evaluating neurologic symptoms in critically ill patients with COVID-19, for diagnosis of underlying neural injury and prognostication of future recovery. The presence of leukoencephalopathy may result in chronic neurologic manifestations and may represent a poor prognosticator of neurologic recovery. The presence of leukoencephalomalacia on follow-up neuroimaging is potentially an indicator of irreversible white matter damage, which may be associated with more severe chronic deficits.
引用
- Lang M, Chang YS, Mehan WA, et al. Long-term neuroimaging follow-up of COVID-19-related leukoencephalopathy. Neuroradiology. 2021. PMID: 34664111. doi:10.1007/s00234-021-02829-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。